Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


30.12.2018

1 AIDS
1 Clin Infect Dis
3 Eur J Gastroenterol Hepatol
1 Hepatology
1 J Clin Gastroenterol
2 J Infect Dis
1 J Med Virol
6 J Viral Hepat
1 JAMA
5 PLoS One
3 Transplant Proc
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. BERENGUER J, Gil-Martin A, Jarrin I, Montes ML, et al
    Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002103.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. LOOMBA R, Decaris M, Li KW, Shankaran M, et al
    Discovery of half-life of circulating HBsAg in patients with chronic hepatitis B infection using heavy water labeling.
    Clin Infect Dis. 2018 Dec 24. pii: 5259172. doi: 10.1093/cid/ciy1100.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. SUAREZ E, Buti M, Rodriguez M, Prieto M, et al
    Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients.
    Eur J Gastroenterol Hepatol. 2019;31:267-271.
    PubMed     Text format     Abstract available

  4. HU Z, Ni P, Fan X, Men R, et al
    Past hepatitis B virus infection was not associated with poorer response or the UK-PBC risk score in ursodeoxycholic acid-treated patients with primary biliary cirrhosis.
    Eur J Gastroenterol Hepatol. 2019;31:277.
    PubMed     Text format    

  5. MARCELLIN F, Protopopescu C, Wittkop L, Salmon-Ceron D, et al
    No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).
    Eur J Gastroenterol Hepatol. 2019;31:274-276.
    PubMed     Text format    


    Hepatology

  6. SEKIBA K, Otsuka M, Ohno M, Yamagami M, et al
    Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, is a potent inhibitor of hepatitis B virus.
    Hepatology. 2018 Dec 26. doi: 10.1002/hep.30491.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  7. PENG S, Wan Z, Liu T, Wang Y, et al
    Quantitative Hepatitis B Surface Antigen Predicts Hepatitis B Transmission in Infants Born to e Antigen-positive Mothers.
    J Clin Gastroenterol. 2018 Dec 19. doi: 10.1097/MCG.0000000000001158.
    PubMed     Text format     Abstract available


    J Infect Dis

  8. SU WJ, Chen SF, Yang CH, Chuang PH, et al
    The Impact of Universal Infant Hepatitis B Immunization on reducing the Hepatitis B Carrier Rate in Pregnant Women.
    J Infect Dis. 2018 Dec 20. pii: 5253892. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. NASTASIO S, Jonas MM
    Editorial: The Impact of Universal Infant Hepatitis B Virus Immunization on reducing the Hepatitis B Carrier Rate in Pregnant Women.
    J Infect Dis. 2018 Dec 20. pii: 5253870. doi: 10.1093.
    PubMed     Text format    


    J Med Virol

  10. BAVARO DF, Saracino A, Fiordelisi D, Bruno G, et al
    Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV co-infected individuals.
    J Med Virol. 2018 Dec 22. doi: 10.1002/jmv.25385.
    PubMed     Text format     Abstract available


    J Viral Hepat

  11. DI LELLO FA, Ridruejo E, Martinez AP, Perez PS, et al
    Molecular epidemiology of hepatitis b virus mutants associated with vaccine-escape, drug-resistance and diagnosis failure.
    J Viral Hepat. 2018 Dec 21. doi: 10.1111/jvh.13052.
    PubMed     Text format     Abstract available

  12. FONG TL, Lee BT, Tien A, Chang M, et al
    Improvement of Bone Mineral Density and Markers of Proximal Renal Tubular Function in Chronic Hepatitis B Patients Switched from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide.
    J Viral Hepat. 2018 Dec 21. doi: 10.1111/jvh.13053.
    PubMed     Text format     Abstract available

  13. RODRIGO C, Leung P, Lloyd AR, Bull RA, et al
    Genomic variability of within-host hepatitis C variants in acute infection.
    J Viral Hepat. 2018 Dec 22. doi: 10.1111/jvh.13051.
    PubMed     Text format     Abstract available

  14. ZHOU L, Li X, Huang X, Chen L, et al
    Soluble Programmed Death-1 Is a Useful Indicator for Inflammatory and Fibrosis Severity in Chronic Hepatitis B.
    J Viral Hepat. 2018 Dec 22. doi: 10.1111/jvh.13055.
    PubMed     Text format     Abstract available

  15. RAMACHANDRAN J, Budd S, Slattery H, Muller K, et al
    Hepatitis C virus infection in Australian psychiatric in-patients: a multicenter study of seroprevalence, risk factors and treatment experience.
    J Viral Hepat. 2018 Dec 21. doi: 10.1111/jvh.13056.
    PubMed     Text format     Abstract available

  16. LOGGI E, Vukotic R, Conti F, Grandini E, et al
    Serum Hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative Chronic Hepatitis B.
    J Viral Hepat. 2018 Dec 21. doi: 10.1111/jvh.13054.
    PubMed     Text format     Abstract available


    JAMA

  17. KUEHN B
    Shifting Hepatitis A Epidemiology.
    JAMA. 2018;320:2522.
    PubMed     Text format    


    PLoS One

  18. PAPIC N, Zidovec Lepej S, Gorenec L, Grgic I, et al
    The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C.
    PLoS One. 2018;13:e0209481.
    PubMed     Text format     Abstract available

  19. KAWAGISHI N, Suda G, Nakamura A, Kimura M, et al
    Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
    PLoS One. 2018;13:e0209615.
    PubMed     Text format     Abstract available

  20. LIU CH, Liu CJ, Su TH, Yang HC, et al
    Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.
    PLoS One. 2018;13:e0209299.
    PubMed     Text format     Abstract available

  21. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Text format     Abstract available

  22. MATSUMOTO K, Wu Y, Kitazawa T, Fujita S, et al
    Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.
    PLoS One. 2018;13:e0199188.
    PubMed     Text format     Abstract available


    Transplant Proc

  23. SUNDARAM V, Wu T, Klein AS, Noureddin M, et al
    Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program.
    Transplant Proc. 2018;50:3527-3532.
    PubMed     Text format     Abstract available

  24. WONG TCL, Fung JYY, Chok KSH, Cheung TT, et al
    Hepatitis B Vaccination in Patients Receiving Oral Antiviral Therapy Without Hepatitis B Immunoglobulin After Liver Transplant.
    Transplant Proc. 2018;50:3681-3688.
    PubMed     Text format     Abstract available

  25. NG C, Danguilan R, Pamugas G, Que E, et al
    Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010.
    Transplant Proc. 2018;50:3242-3248.
    PubMed     Text format     Abstract available


    Vaccine

  26. VAN MULDER TJS, Withanage K, Beyers KCL, Vankerckhoven VVJ, et al
    Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID.
    Vaccine. 2018 Dec 23. pii: S0264-410X(18)31676.
    PubMed     Text format     Abstract available


    Virology

  27. XUE W, Zhao Q, Li P, Zhang R, et al
    Identification and characterization of a novel nanobody against duck hepatitis A virus type 1.
    Virology. 2018;528:101-109.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: